Treatment of POEMS Syndrome With Daratumumab

NCT04396496 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Arkansas

Collaborators